September 2026
1. JIANG L, Dai Z, Zhu C
   An Unexpected Cause of Severe Steatohepatitis in a Young Male.
   Gastroenterology. 2026 Sep 30:S0016-5085(26)07328.
   

   >> Share

   
   
2. MCCOY MS, Peiffer KH, Hahner JM, Praktiknjo M, et al
   When the Beat and the Bleed Compete: An Opportunity for INTERBLEED Subgroup Analysis in Patients With Liver Cirrhosis.
   Gastroenterology. 2026 Sep 21:S0016-5085(26)07256.
   

   >> Share

   
   August 2026
3. LIU A
   Carvedilol Continues to Win: A Target Trial Emulation Study Comparing Carvedilol Against Other Nonselective B-Blockers in Cirrhosis.
   Gastroenterology. 2026 Aug 21:S0016-5085(26)07183.
   

   >> Share

   
   
4. PIRZADA SA, Ghany MG
   HBsAg Loss and Hepatocellular Carcinoma Surveillance: One Size Does Not Fit All.
   Gastroenterology. 2026 Aug 17:S0016-5085(26)07166.
   

   >> Share

   
   
5. YIN D, Vazquez Salgado AM, Cai C, Wang AW, et al
   Liver regeneration CRISPR screen identifies E3 ligase NEURL1B regulates hepatocyte mitosis by destabilizing microtubule organizing centers.
   Gastroenterology. 2026 Aug 14:S0016-5085(26)07156.
   

   >> Share

   
   
6. AJMERA V, Huang DQ, Chen VL, Reddy KR, et al
   Monogenic and Polygenic Risk in Common Liver Diseases: Implications for Clinical Care.
   Gastroenterology. 2026;171:253-270.
   

   >> Share

   
   July 2026
7. MURALIDHARAN S, Yao R, Park S, Weiner-Light S, et al
   Beyond Burnout: Recognizing and Reframing the Heartsink Response in Gastroenterologists and Hepatologists.
   Gastroenterology. 2026 Jul 22:S0016-5085(26)07068.
   

   >> Share

   
   
8. EL-DEBEIKY S, Hiu-Fung Lam T, Sze-Man Lai M, Tse YK, et al
   Long-term incidence of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
   Gastroenterology. 2026 Jul 13:S0016-5085(26)07043.
   

   >> Share

   
   
9. KANWAL F, Bril F, Wong VW, Adams LA, et al
   Clinical Care Pathway for the Risk Stratification and Management of Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
   Gastroenterology. 2026;171:164-183.
   

   >> Share

   
   June 2026
10. KATO S, Hikita H, Takehara T
    Reply to "Critical Appraisal of the Integrin alphaV-YAP-CTGF Axis in Congestive Hepatopathy".
    Gastroenterology. 2026 Jun 26:S0016-5085(26)06989.
    

    >> Share

    
    
11. SUN J, Guan Z, Liu Y
    Critical Appraisal of the Integrin alphaV-YAP-CTGF Axis in Congestive Hepatopathy.
    Gastroenterology. 2026 Jun 26:S0016-5085(26)06988.
    

    >> Share

    
    
12. KWO PY, Masuoka HC, Schaefer EA, Friedman LS, et al
    Evaluation of Abnormal Liver Biochemical Test Results.
    Gastroenterology. 2026;170:1457-1472.
    

    >> Share

    
    
13. KIM GA, Jang H, Kim MY, Park JH, et al
    Multicenter Prospective Cohort Study on Clinical Outcomes and Fibrosis Patterns in Biopsy-Proven Steatotic Liver Disease Subtypes.
    Gastroenterology. 2026;170:1571-1583.
    

    >> Share

    
    May 2026
14. BELZ L, van den Heuvel D, Kilani B, Martinez-Navarro A, et al
    Neutrophil-Driven Trogocytosis in Pancreatic Ductal Adenocarcinoma Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression.
    Gastroenterology. 2026 May 6:S0016-5085(26)06818.
    

    >> Share

    
    
15. KIM A, Alligood DM, Maram L, Phelps HM, et al
    A Gut-Restricted Liver X Receptor Agonist Ameliorates Liver Injury in Experimental Short Bowel Syndrome.
    Gastroenterology. 2026;170:1017-1032.
    

    >> Share

    
    
16. TAVAGLIONE F, Vaz J, Jamialahmadi O, Diaz LA, et al
    The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use.
    Gastroenterology. 2026;170:1033-1046.
    

    >> Share

    
    April 2026
17. PARIKH ND, Singal AG
    Not So Fast, My Friend: Biomarkers May Play an Important Role in Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2026 Apr 29:S0016-5085(26)06769.
    

    >> Share

    
    
18. NI B, Wang H
    Toward Precision Hepatocellular Carcinoma Surveillance: Standardizing Ultrasound Visualization and Optimizing Biomarker Integration.
    Gastroenterology. 2026 Apr 29:S0016-5085(26)06768.
    

    >> Share

    
    
19. YANG H, Zhao S, Fan R
    Optimizing the Evaluation of Biomarkers for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2026 Apr 29:S0016-5085(26)06770.
    

    >> Share

    
    
20. RICH NE, Villanueva A, Marrero JA, Kanwal F, et al
    AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2026 Apr 15:S0016-5085(26)00243.
    

    >> Share

    
    
21. CARTER JA, Dickerson LK, Stephanou A, Damle SR, et al
    Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar Carcinoma.
    Gastroenterology. 2026;170:787-802.
    

    >> Share

    
    
22. TORP N, Johansen S, Jensen EL, Maagaard M, et al
    Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease.
    Gastroenterology. 2026;170:803-814.
    

    >> Share

    
    
23. LOOMBA R, Clark VC, Mandorfer M, Miravitlles M, et al
    Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
    Gastroenterology. 2026;170:829-842.
    

    >> Share

    
    
24. BALAJI S, Bhat M
    Building the Human Liver in a Dish: Organoids, Assembloids and the Road to Precision Hepatology.
    Gastroenterology. 2026 Apr 1:S0016-5085(26)00310.
    

    >> Share

    
    March 2026
25. MULLISH BH, Mullish BH
    Efimosfermin, a fibroblast growth factor 21 analogue, for metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2026 Mar 23:S0016-5085(26)00256.
    

    >> Share

    
    
26. TAO X, Jiang W, Tang H
    A Mysterious Case of Diffuse Severe Hepatic Steatosis in a Thin Teenager.
    Gastroenterology. 2026 Mar 23:S0016-5085(26)00255.
    

    >> Share

    
    
27. SCARALLO L, Alvisi P, Bramuzzo M, Domanico A, et al
    Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN.
    Gastroenterology. 2026 Mar 16:S0016-5085(26)00232.
    

    >> Share

    
    
28. SARIN SK, Tripathti DM, Lohse AW
    Non-cirrhotic Portal Fibrosis, Idiopathic Portal Hypertension and Porto-sinusoidal Vascular Diseases: From Debates to Future Directions.
    Gastroenterology. 2026 Mar 10:S0016-5085(26)00199.
    

    >> Share

    
    
29. WANG M, Chen F, Gao J, Liu Q, et al
    Clusterin Drives Fiber Endocytosis by Mesothelial Cells to Resolve Liver Fibrosis.
    Gastroenterology. 2026;170:569-583.
    

    >> Share

    
    February 2026
30. KATO S, Hikita H, Tsukamoto O, Sato K, et al
    Activation of the Integrin alphaV-YAP-CTGF Axis in Liver Sinusoidal Endothelial Cells Promotes Liver Fibrogenesis, Leading to Portal Hypertension and Liver Carcinogenesis in Congestive Hepatopathy.
    Gastroenterology. 2026 Feb 27:S0016-5085(25)06526.
    

    >> Share

    
    
31. LUO J
    Machine Learning in Cirrhosis: Moving from Static Admission Risk to Dynamic Decision Support.
    Gastroenterology. 2026 Feb 11:S0016-5085(26)00121.
    

    >> Share

    
    
32. TAKEFUJI Y
    Enhancing Inpatient Mortality Prognostication in Cirrhosis Patients Through Machine Learning Techniques.
    Gastroenterology. 2026 Feb 11:S0016-5085(26)00120.
    

    >> Share

    
    
33. GIAMOURIS VJ, Grammatikopoulos T
    Response to "The Natural History of Gastroesophageal Varices in Children With Portal Hypertension".
    Gastroenterology. 2026 Feb 10:S0016-5085(26)00119.
    

    >> Share

    
    
34. ACEITUNO L, Banares J, Pons M, Rivera-Esteban J, et al
    The ANTICIPATE-NASH Models Stratify Better the Risk of Clinical Events Than Histology in Metabolic Dysfunction-Associated Steatotic Liver Disease Patients With Advanced Chronic Liver Disease.
    Gastroenterology. 2026;170:385-394.
    

    >> Share

    
    
35. LEE TH, Duong N, Simonetto DA, Paul S, et al
    Knowledge, Attitudes, and Environment Related to Gastroenterology and Hepatology Care for Sexual and Gender Minorities.
    Gastroenterology. 2026;170:246-251.
    

    >> Share

    
    January 2026
36. MULLISH BH
    Improving efficacy without increasing side effects? Exploring the impact of a novel GLP-1-glucagon dual receptor agonist upon metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2026 Jan 29:S0016-5085(26)00083.
    

    >> Share

    
    
37. HIRODE G, Zangneh HF, Cerocchi O, Khalili K, et al
    Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial.
    Gastroenterology. 2026 Jan 20:S0016-5085(25)05993.
    

    >> Share

    
    December 2025
38. IQBAL J, Sathian B, Ali SM
    Comments on Hepatic Stellate Cell Regulation in Metabolic Dysfunction-Associated Steatohepatitis.
    Gastroenterology. 2025 Dec 18:S0016-5085(25)06664.
    

    >> Share

    
    November 2025
39. DENG ZL, Safaei N, Schutte SL, Ohlendorf V, et al
    High Prevalence and Local Dissemination of Daptomycin-Resistance Mutations for Enterococcus faecium in Cirrhotic Patients.
    Gastroenterology. 2025 Nov 19:S0016-5085(25)06045.
    

    >> Share

    
    
40. KIM NJ, Li M, Vutien P, Mecham B, et al
    Changes in Liver Disease Etiology Support a Lower Alpha-Fetoprotein Threshold for Hepatocellular Carcinoma Screening.
    Gastroenterology. 2025 Nov 14:S0016-5085(25)05906.
    

    >> Share

    
    
41. LI S, Zhong Y, Yang Y
    A rare etiology of hepatic steatosis.
    Gastroenterology. 2025 Nov 12:S0016-5085(25)06480.
    

    >> Share

    
    October 2025
42. ORMAN ES, Fortune BE, John BV, Asrani SK, et al
    AGA Clinical Practice Update on the Management of Ascites, Volume Overload, and Hyponatremia in Cirrhosis: Expert Review.
    Gastroenterology. 2025 Oct 20:S0016-5085(25)05959.
    

    >> Share

    
    
43. FOX D, Xie J, Burwinkel JL, Adams JM, et al
    Adeno-associated Virus-mediated Silencing of Sox4 Leads to Long-Term Amelioration of Liver Phenotypes in Mouse Models of Alagille Syndrome.
    Gastroenterology. 2025;169:1000-1016.
    

    >> Share

    
    September 2025
44. SINGAL AG, Salem R, Pinato DJ, Pillai A, et al
    Advances in Locoregional and Systemic Treatments for Hepatocellular Carcinoma.
    Gastroenterology. 2025;169:585-599.
    

    >> Share

    
    
45. ROHM TV, Dos Reis FCG, Cunha E Rocha K, Isaac R, et al
    Adipose Tissue Macrophages in Metabolic Dysfunction-Associated Steatohepatitis Secrete Extracellular Vesicles That Activate Liver Fibrosis in Obese Male Mice.
    Gastroenterology. 2025;169:691-704.
    

    >> Share

    
    
46. JIANG C, Li Z, Seok S, Li P, et al
    Systemic Identification of Functionally Conserved Long Noncoding RNA Metabolic Regulators in Human and Mouse Livers.
    Gastroenterology. 2025;169:676-690.
    

    >> Share

    
    August 2025
47. LI L, Wang Y, Deng B
    A Patient with Liver Injury, Portal Hypertension, Anemia, and Peripheral Neuropathy.
    Gastroenterology. 2025 Aug 25:S0016-5085(25)05908.
    

    >> Share

    
    
48. LOU TW, Ren TY, Fan JG
    An Unusual Cause of Hypolipidemia With Cirrhosis in a Father-Son Pair.
    Gastroenterology. 2025 Aug 21:S0016-5085(25)05901.
    

    >> Share

    
    
49. LIU WY, Huang S, Ji H, Kim SU, et al
    From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective.
    Gastroenterology. 2025;169:326-336.
    

    >> Share

    
    
50. SPANN A, Strauss AT, Davis SE, Bhat M, et al
    The Role of Artificial Intelligence in Chronic Liver Diseases and Liver Transplantation.
    Gastroenterology. 2025;169:456-470.
    

    >> Share

    
    July 2025
51. RUSSI AE, DeBosch BJ
    Interdicting nuclear autophagy to treat metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2025 Jul 29:S0016-5085(25)05794.
    

    >> Share

    
    
52. SHI X
    Visualization Score Might be Considered for Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2025 Jul 23:S0016-5085(25)05788.
    

    >> Share

    
    
53. FERNANDEZ-GARIBAY VM, Chavez-Tapia NC
    Thoughts on "Noncontrast magnetic resonance imaging vs ultrasonography for hepatocellular carcinoma surveillance".
    Gastroenterology. 2025 Jul 23:S0016-5085(25)05791.
    

    >> Share

    
    
54. WANG Y, Huang Y, Zhang G, Wang S, et al
    Noncontrast MRI in Hepatocellular Carcinoma Surveillance: Considerations for Implementation in Clinical Practice.
    Gastroenterology. 2025 Jul 23:S0016-5085(25)05790.
    

    >> Share

    
    
55. SILVEY S, Kamath PS, George J, Choudhury A, et al
    Enhancement of Inpatient Mortality Prognostication with Machine Learning in a Prospective Global Cohort of Patients with Cirrhosis with External Validation.
    Gastroenterology. 2025 Jul 18:S0016-5085(25)05770.
    

    >> Share

    
    
56. ACKERMANN O, Bernard O, Franchi-Abella S, Almes M, et al
    The natural history of gastroesophageal varices in children with portal hypertension.
    Gastroenterology. 2025 Jul 15:S0016-5085(25)05748.
    

    >> Share

    
    June 2025
57. JING S, Song J
    Comments on "Multi-HCC: A Practical Model to Prioritize Patients With Hepatocellular Carcinoma on the Liver Transplant Waiting List".
    Gastroenterology. 2025 Jun 10:S0016-5085(25)00884.
    

    >> Share

    
    
58. BAJAJ JS, Shawcross DL, Choudhury A, Karvellas CJ, et al
    Defining Organ Failures in Patients with Cirrhosis: Consensus Statements.
    Gastroenterology. 2025 Jun 9:S0016-5085(25)00844.
    

    >> Share

    
    
59. MCGETTIGAN B, Hernandez-Tejero M, Malhi H, Shah V, et al
    Immune Dysfunction and Infection Risk in Advanced Liver Disease.
    Gastroenterology. 2025;168:1085-1100.
    

    >> Share

    
    May 2025
60. JUANOLA A, Ma AT, Cullaro G, Alexander MP, et al
    DEVELOPMENT OF ACUTE KIDNEY INJURY IN A PATIENT WITH ALCOHOL-RELATED CIRRHOSIS: THE IMPORTANCE OF DIAGNOSING THE CAUSE OF AKI.
    Gastroenterology. 2025 May 19:S0016-5085(25)00764.
    

    >> Share

    
    
61. XUE H, Wang L, Sun D, Wu Y, et al
    Associations of alcohol consumption and genetic predisposition to hepatic steatosis with liver-related events: results from large population-based cohort studies.
    Gastroenterology. 2025 May 14:S0016-5085(25)00712.
    

    >> Share

    
    
62. SHUNG DL, Iacucci M
    Artificial Intelligence in Gastroenterology and Hepatology: Potential and Perils.
    Gastroenterology. 2025 May 13:S0016-5085(25)00710.
    

    >> Share

    
    April 2025
63. HUPPERTZ I, Mullen AC
    Function over form: defining evolutionarily conserved long-noncoding RNAs regulating hepatic metabolism.
    Gastroenterology. 2025 Apr 25:S0016-5085(25)00641.
    

    >> Share

    
    
64. LENS S
    Simvastatin and Rifaximin for Decompensated Cirrhosis: A Hope Unfulfilled.
    Gastroenterology. 2025 Apr 23:S0016-5085(25)00638.
    

    >> Share

    
    
65. YOUNOSSI ZM, Zelber-Sagi S, Lazarus JV, Wai-Sun Wong V, et al
    Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.
    Gastroenterology. 2025 Apr 11:S0016-5085(25)00632.
    

    >> Share

    
    
66. GUPTA V, Sehrawat TS, Pinzani M, Strazzabosco M, et al
    Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities.
    Gastroenterology. 2025;168:675-690.
    

    >> Share

    
    March 2025
67. SILVEY S, Patel N, Khoruts A, Bajaj JS, et al
    Rifaximin does not increase the rate of 30-day mortality in patients with cirrhosis and daptomycin in two National US-based cohorts.
    Gastroenterology. 2025 Mar 21:S0016-5085(25)00535.
    

    >> Share

    
    
68. KISSELEVA T, Ganguly S, Murad R, Wang A, et al
    Regulation of Hepatic Stellate Cell Phenotypes in MASH.
    Gastroenterology. 2025 Mar 20:S0016-5085(25)00528.
    

    >> Share

    
    February 2025
69. PAN S, Chen J, Li X
    An Unusual Case of Unexplained Portal Hypertension and Splenomegaly.
    Gastroenterology. 2025 Feb 18:S0016-5085(25)00374.
    

    >> Share

    
    
70. PEERY AF, Murphy CC, Anderson C, Jensen ET, et al
    Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2024.
    Gastroenterology. 2025 Feb 4:S0016-5085(25)00034.
    

    >> Share

    
    
71. FROMME M, Payance A, Mandorfer M, Thorhauge KH, et al
    Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi *ZZ Genotype).
    Gastroenterology. 2025;168:367-381.
    

    >> Share

    
    January 2025
72. KUMAR N, Chaudhary A
    Comments on "Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program".
    Gastroenterology. 2025 Jan 30:S0016-5085(25)00326.
    

    >> Share

    
    
73. KRONSTEN VT, Paintsil EK, Rodrigues S, Seager MJ, et al
    Hepatic encephalopathy - when lactulose and rifaximin are not working.
    Gastroenterology. 2025 Jan 24:S0016-5085(25)00050.
    

    >> Share

    
    
74. RHEE H, Kim MJ, Kim DY, An C, et al
    Non-contrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance: A randomized, single-center trial.
    Gastroenterology. 2025 Jan 22:S0016-5085(25)00049.
    

    >> Share

    
    December 2024
75. DAVIS JPE, Lim JK, Francis FF, Ahn J, et al
    AGA Clinical Practice Update on Management of Portal Vein Thrombosis in Patients With Cirrhosis: Expert Review.
    Gastroenterology. 2024 Dec 20:S0016-5085(24)05664.
    

    >> Share

    
    November 2024
76. NORMAN J, Mehta N, Kim WR, Liang JW, et al
    Multi-HCC: A practical model to prioritize patients with hepatocellular carcinoma on the liver transplant waiting list.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05754.
    

    >> Share

    
    
77. MEZZACAPPA C
    Gastro Digest: The Revised REACH-B Model Predicts Hepatocellular Carcinoma in Patients with Chronic Hepatitis B.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05756.
    

    >> Share

    
    
78. MULLISH BH
    New agonists of the incretin/glucagon system for the treatment of metabolic dysfunction-associated steatohepatitis.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05755.
    

    >> Share

    
    
79. FOERSTER F, Galle PR
    To Look or Not to Look: A New Score for Stratifying Patients at Risk of Developing Hepatocellular Carcinoma.
    Gastroenterology. 2024 Nov 30:S0016-5085(24)05753.
    

    >> Share

    
    
80. ELLER M, Westbrook L, Kalra A
    Expanding the Differential Diagnosis: Severe, Swollen Hepatocytes in a Patient with an ALT above 1000 U/L.
    Gastroenterology. 2024 Nov 16:S0016-5085(24)05697.
    

    >> Share

    
    
81. FUJIWARA N, Lopez C, Marsh TL, Raman I, et al
    Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis.
    Gastroenterology. 2024 Nov 7:S0016-5085(24)05660.
    

    >> Share

    
    
82. DE ALMEIDA SOUZA GL, Chebli VA, Fonseca Chebli JM
    An intriguing case of hepatosplenic lesions and pneumonia during anti-TNF therapy for IBD.
    Gastroenterology. 2024 Nov 6:S0016-5085(24)05661.
    

    >> Share

    
    
83. DORNER H, Stolzer I, Mattner J, Kaminski S, et al
    Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease.
    Gastroenterology. 2024;167:1183-1197.
    

    >> Share

    
    October 2024
84. WANG Z, Li J, Li Y
    Insights into the protective role of GLP-1RAs in the treatment of type 2 diabetes mellitus: implications for hepatocellular carcinoma and hepatic dysfunction.
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05578.
    

    >> Share

    
    
85. WEI JC, Wu CN, Cheng WC
    Comments on "Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes".
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05581.
    

    >> Share

    
    
86. WEI JC, Kuo P, Mei Q
    Methodology of Study on GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk.
    Gastroenterology. 2024 Oct 17:S0016-5085(24)05579.
    

    >> Share

    
    
87. LIU Z, Shan D, Han X
    GLP-1 Receptor Agonists' Role in Reducing Hepatocellular Carcinoma Risk.
    Gastroenterology. 2024 Oct 16:S0016-5085(24)05580.
    

    >> Share

    
    
88. RATHORE M, Curry K, Huang W, Wright M, et al
    LRG1 promotes metastatic colorectal cancer growth through HER3 signaling.
    Gastroenterology. 2024 Oct 9:S0016-5085(24)05566.
    

    >> Share

    
    
89. KOTHARI S, Afshar Y, Friedman LS, Ahn J, et al
    AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review.
    Gastroenterology. 2024;167:1033-1045.
    

    >> Share

    
    
90. HUPERTZ VF
    A Further Step Toward Possible Treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
    Gastroenterology. 2024;167:847-848.
    

    >> Share

    
    
91. CLARK VC, Strange C, Strnad P, Sanchez AJ, et al
    Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA).
    Gastroenterology. 2024;167:1008-1018.
    

    >> Share

    
    
92. ALLEGRETTI JR, Khanna S, Mullish BH, Feuerstadt P, et al
    The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond.
    Gastroenterology. 2024;167:885-902.
    

    >> Share

    
    September 2024
93. MAK LY, Yuen MF
    Surveillance for hepatocellular carcinoma in cirrhosis: End of monopoly for serum alpha fetoprotein.
    Gastroenterology. 2024 Sep 28:S0016-5085(24)05533.
    

    >> Share

    
    
94. MARSH TL, Parikh ND, Roberts LR, Schwartz ME, et al
    A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis.
    Gastroenterology. 2024 Sep 16:S0016-5085(24)05460.
    

    >> Share

    
    
95. GINES P, Serra-Burriel M
    Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus: Growing Evidence But Not Yet There.
    Gastroenterology. 2024;167:653-655.
    

    >> Share

    
    
96. ASOMBANG AW, Mohamed MF, Egboh SC, Omede M, et al
    The Importance of Global Health Training in US-Based Gastroenterology and Hepatology Fellowship Programs.
    Gastroenterology. 2024;167:643-648.
    

    >> Share

    
    August 2024
97. PREMKUMAR M, Dhiman RK, Duseja A, Mehtani R, et al
    Recompensation of Chronic Hepatitis C-related decompensated cirrhosis following direct-acting antiviral therapy: Prospective Cohort study from an HCV elimination program.
    Gastroenterology. 2024 Aug 22:S0016-5085(24)05359.
    

    >> Share

    
    
98. GIBBENS Y, Lake J, Lim N
    A Rare Cause of Acute Liver Failure.
    Gastroenterology. 2024;167:446-449.
    

    >> Share

    
    
99. CHENG X, Dai E, Wu J, Flores NM, et al
    Atlas of metastatic gastric cancer links ferroptosis to disease progression and immunotherapy response.
    Gastroenterology. 2024 Aug 1:S0016-5085(24)05297.
    

    >> Share

    
    July 2024
100. VAN KLEEF LA, Francque SM, Prieto-Ortiz JE, Sonneveld MJ, et al
     Metabolic Dysfunction-Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction.
     Gastroenterology. 2024;167:357-367.
     

     >> Share

     
     
101. NAIMIMOHASSES S, Bhat M
     Novel Multimodal Database for Metabolic Dysfunction-Associated Steatotic Liver Disease-Linking Genes to Outcomes.
     Gastroenterology. 2024;167:410-411.
     

     >> Share

     
     
102. SUI B, Wang R, Chen C, Kou X, et al
     Apoptotic Vesicular Metabolism Contributes to Organelle Assembly and Safeguards Liver Homeostasis and Regeneration.
     Gastroenterology. 2024;167:343-356.
     

     >> Share

     
     June 2024
103. ZENG T, Xiong J, Li X
     A rare cause of hepatic mass with high metabolic activity and jaundice.
     Gastroenterology. 2024 Jun 29:S0016-5085(24)05173.
     

     >> Share

     
     
104. SUTTON H, Bhat M
     Novel migratory hepatocyte population contributes to liver regeneration in acute liver injury.
     Gastroenterology. 2024 Jun 27:S0016-5085(24)05176.
     

     >> Share

     
     
105. KO S, Monga SP
     The dark side of human hepatocyte plasticity.
     Gastroenterology. 2024 Jun 25:S0016-5085(24)05116.
     

     >> Share

     
     
106. LENS S
     Resmetirom for Non-alcoholic Steatohepatitis.
     Gastroenterology. 2024 Jun 25:S0016-5085(24)05120.
     

     >> Share

     
     
107. VENKATESWARAN N
     Seladelpar as an alternate second line agent for Primary Biliary Cirrhosis.
     Gastroenterology. 2024 Jun 20:S0016-5085(24)05064.
     

     >> Share

     
     
108. ZHU CP, Liu SQ, Wang KQ, Xiong HL, et al
     Targeting 5-Hydroxytryptamine receptor 1A in portal vein to decrease portal hypertension.
     Gastroenterology. 2024 Jun 19:S0016-5085(24)05062.
     

     >> Share

     
     
109. HSU BY, Driscoll J, Tateno C, Mattis AN, et al
     Human Hepatocytes Can Give Rise To Intrahepatic Cholangiocarcinomas.
     Gastroenterology. 2024 Jun 10:S0016-5085(24)05028.
     

     >> Share

     
     
110. LEE BP, Louvet A
     Longitudinal Change of Alcohol Use is a Dynamic Contributor to Steatotic Liver Disease Progression.
     Gastroenterology. 2024;166:965-967.
     

     >> Share

     
     
111. LO GH
     The Optimal Duration of Vasoconstrictors for Acute Variceal Hemorrhage: Longer Is Safer?
     Gastroenterology. 2024;166:1197-1198.
     

     >> Share

     
     
112. WANG H, Yuan S, Zheng Q, Zhang S, et al
     Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs.
     Gastroenterology. 2024;166:1130-1144.
     

     >> Share

     
     May 2024
113. HANSCOM M
     Magnetically guided capsule endoscopy comparable to EGD for detecting esophagogastric varices in patients with cirrhosis.
     Gastroenterology. 2024 May 28:S0016-5085(24)05001.
     

     >> Share

     
     
114. WANG R, Li B, Huang B, Li Y, et al
     Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis.
     Gastroenterology. 2024 May 27:S0016-5085(24)04936.
     

     >> Share

     
     
115. HILSCHER MB, Wysokinski WE, Andrews JC, Simonetto DA, et al
     Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies.
     Gastroenterology. 2024 May 25:S0016-5085(24)04951.
     

     >> Share

     
     
116. CHANG M, Hammami MB, Sakiani S
     A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
     Gastroenterology. 2024 May 14:S0016-5085(24)04914.
     

     >> Share

     
     
117. NIEMI NM, Debosch BJ
     Survival of the Fittest: Clonal Selection of Somatic Mutations Reveals Targets to Abate Chronic Liver Injury.
     Gastroenterology. 2024;166:936-937.
     

     >> Share

     
     
118. GEORGE B, Kudryashova O, Kravets A, Thalji S, et al
     Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
     Gastroenterology. 2024;166:859-871.
     

     >> Share

     
     
119. SCHONAUER R, Sierks D, Boerrigter M, Jawaid T, et al
     Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease.
     Gastroenterology. 2024;166:902-914.
     

     >> Share

     
     April 2024
120. WANG L, Berger NA, Kaelber DC, Xu R, et al
     Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes.
     Gastroenterology. 2024 Apr 29:S0016-5085(24)00494.
     

     >> Share

     
     
121. JIANG C, Lian M, Ma X
     A Rare Case Mimicking Congenital Hepatic Fibrosis.
     Gastroenterology. 2024 Apr 23:S0016-5085(24)00483.
     

     >> Share

     
     March 2024
122. CAMPANI C, Guido M, Marra F
     Elusive hepatic nodules.
     Gastroenterology. 2024 Mar 23:S0016-5085(24)00355.
     

     >> Share

     
     
123. HOLTZ LR, DeBosch BJ
     Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
     Gastroenterology. 2024;166:534-535.
     

     >> Share

     
     
124. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
     PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
     Gastroenterology. 2024;166:515-517.
     

     >> Share

     
     
125. GAO F, Seto WK, Zheng MH
     Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
     Gastroenterology. 2024;166:541-542.
     

     >> Share

     
     
126. AN T, Liu L, Li X
     Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
     Gastroenterology. 2024;166:540-541.
     

     >> Share

     
     February 2024
127. WONG RJ, Yang Z, Cheung R, Singal AK, et al
     Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among U.S. Veterans with Steatotic Liver Disease.
     Gastroenterology. 2024 Feb 28:S0016-5085(24)00238.
     

     >> Share

     
     
128. CHEN J, Feng W, Sun M, Huang W, et al
     TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
     Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
     

     >> Share

     
     
129. LENS S
     In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis.
     Gastroenterology. 2024 Feb 20:S0016-5085(24)00185.
     

     >> Share

     
     
130. HERMS Q, Fuster-Anglada C, Juanola A
     Pembrolizumab-induced Liver Injury: Beyond Immune-Mediated Hepatitis.
     Gastroenterology. 2024 Feb 4:S0016-5085(24)00133.
     

     >> Share

     
     
131. ALLEN AM, Pose E, Reddy KR, Russo MW, et al
     Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges.
     Gastroenterology. 2024;166:229-234.
     

     >> Share

     
     
132. WALAYAT S, Pfau P
     2 AM in the Intensive Care Unit: What Could Go Wrong?
     Gastroenterology. 2024;166:e13-e15.
     

     >> Share

     
     
133. BILAL M, Steinberg J, Louissaint J, Phan J, et al
     First Year on the Job as a Gastroenterologist and Hepatologist: Lessons Learned.
     Gastroenterology. 2024 Feb 1:S0016-5085(24)00125.
     

     >> Share

     
     January 2024
134. POSE E, Piano S, Juanola A, Gines P, et al
     HEPATORENAL SYNDROME IN CIRRHOSIS.
     Gastroenterology. 2024 Jan 19:S0016-5085(24)00054.
     

     >> Share

     
     
135. LAURIDSEN MM, Gronkjaer LL, Khraibut S, Patel N, et al
     The multi-dimensional challenge of poor oral health in cirrhosis - disparities and solutions.
     Gastroenterology. 2024 Jan 13:S0016-5085(24)00043.
     

     >> Share

     
     
136. MULLISH BH
     Risk Factors for Liver Cancer and Chronic Liver Disease-related Death: Are Sugar Substitutes Better Than the Real Thing?
     Gastroenterology. 2024;166:213-214.
     

     >> Share

     
     
137. ZENG Q, Wu D, Tang H
     A Mysterious Abdominal Pain.
     Gastroenterology. 2024;166:27-30.
     

     >> Share

     
     December 2023
138. MEZZACAPPA C, Bhat M
     Proteomic Panels for Alcohol-Associated Liver Disease: Accurate, but Different Enough From Existing Clinical Tests?
     Gastroenterology. 2023;165:1576.
     

     >> Share

     
     November 2023
139. GARCIA-TSAO G, Abraldes JG, Rich NE, Wong VW, et al
     AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
     Gastroenterology. 2023 Nov 17:S0016-5085(23)05143.
     

     >> Share

     
     
140. KOJIMA H, Kadono K, Hirao H, Dery KJ, et al
     T Cell CEACAM1-TIM-3 Crosstalk Alleviates Liver Transplant Injury in Mice and Humans.
     Gastroenterology. 2023;165:1233-1248.
     

     >> Share

     
     
141. PENA-SANCHEZ JN, Osei JA, Teucher U, Tremblay M, et al
     Working With Indigenous Community and Patient Partners Is Essential to Advance Gastroenterology and Hepatology Research: Perspectives From Canada.
     Gastroenterology. 2023;165:1097-1101.
     

     >> Share

     
     
142. LLOVET JM, Heikenwalder M
     Atezolizumab Plus Bevacizumab in Advanced HCC: Efficacy in NASH-Specific Etiology.
     Gastroenterology. 2023;165:1308-1310.
     

     >> Share

     
     
143. ALBRECHT T, Rossberg A, Albrecht JD, Nicolay JP, et al
     Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.
     Gastroenterology. 2023;165:1262-1275.
     

     >> Share

     
     October 2023
144. AMPUERO J, Berzigotti A
     Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant.
     Gastroenterology. 2023;165:829-831.
     

     >> Share

     
     
145. SEMMLER G, Yang Z, Fritz L, Kock F, et al
     Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
     Gastroenterology. 2023;165:1041-1052.
     

     >> Share

     
     
146. MAN S, Deng Y, Ma Y, Fu J, et al
     Prevalence of Liver Steatosis and Fibrosis in the General Population and Various High-Risk Populations: A Nationwide Study With 5.7 Million Adults in China.
     Gastroenterology. 2023;165:1025-1040.
     

     >> Share

     
     
147. YIP TC, Fan JG, Wong VW
     China's Fatty Liver Crisis: A Looming Public Health Emergency.
     Gastroenterology. 2023;165:825-827.
     

     >> Share

     
     
148. TICA S, Debosch BJ
     Bariatric Surgery for the Treatment of NASH-An Old Solution to a Newer Problem?
     Gastroenterology. 2023;165:1091.
     

     >> Share

     
     
149. WATTACHERIL JJ, Abdelmalek MF, Lim JK, Sanyal AJ, et al
     AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.
     Gastroenterology. 2023;165:1080-1088.
     

     >> Share

     
     September 2023
150. CHEN J, Yang Q, Wang C
     Multiple Hepatic Masses in a Patient with Crohn's disease.
     Gastroenterology. 2023 Sep 20:S0016-5085(23)05014.
     

     >> Share

     
     
151. XIE L, Guo H
     Question on the use of BMI >/= 25 kg/m(2) to define obesity to analyze the incidence and risk factors of hepatic steatosis and hepatic fibrosis in the Chinese population.
     Gastroenterology. 2023 Sep 8:S0016-5085(23)04983.
     

     >> Share

     
     
152. MEZZACAPPA C
     Survival in unresectable hepatocellular carcinoma treated with a new immune checkpoint and anti-angiogenic drug combination.
     Gastroenterology. 2023 Sep 6:S0016-5085(23)04976.
     

     >> Share

     
     August 2023
153. SHEN C, Zhang J, Xia Q
     Unexpected Abdominal Wall Varices After Split-Liver Transplantation.
     Gastroenterology. 2023;165:354-356.
     

     >> Share

     
     March 2023
154. GADIYARAM S, Nachiappan M, Kini D
     Liver SOL in a case of colon cancer, a red herring.
     Gastroenterology. 2023 Mar 24:S0016-5085(23)00534.
     

     >> Share

     
     
155. KO PH, Tseng CW
     An Unusual Cause of Acute Cholecystitis.
     Gastroenterology. 2023 Mar 23:S0016-5085(23)00531.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share